Who is sponsoring NCT05903638?

NCT05903638 is sponsored by One Fertility.

What drugs are being tested in NCT05903638?

Interventions in NCT05903638: Mindfulness-Based Stress Reduction course.

What condition does NCT05903638 study?

NCT05903638 studies Primary Infertility, Mental Health Issue, Quality of Life.

Is NCT05903638 still recruiting?

NCT05903638 is currently status unknown. Last updated 15 June 2023.

Last reviewed 2023-06-15 · How we verify

NCT05903638

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Pilot RCT: the Impact of a Virtual MBSR Course on Women With Primary Infertility

Status unknown NA Last updated 15 June 2023

What this trial tests

NA trial testing Mindfulness-Based Stress Reduction course in Primary Infertility in 24 participants. Status unknown.

Timeline

30 September 2022

Primary endpoint
31 March 2023

30 September 2023

Quick facts

Lead sponsor	One Fertility
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	supportive care
Enrollment	24
Start date	30 September 2022
Primary completion	31 March 2023
Estimated completion	30 September 2023
Sites	1 location across Canada

Drugs / interventions tested

Mindfulness-Based Stress Reduction course

Conditions studied

Primary Infertility — all drugs for Primary Infertility →
Mental Health Issue — all drugs for Mental Health Issue →
Quality of Life — all drugs for Quality of Life →

Sponsor

One Fertility

Who can join

18 and older, female only, with Primary Infertility or Mental Health Issue. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We plan to perform a pilot study in which women with primary infertility seeking an initial fertility consultation will be randomized into either a standard treatment group or an 8-week virtual Mindfulness-Based Stress Reduction (MBSR) program. Primary outcomes included retention and survey completion rates. Secondary outcomes included Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), Perceived Stress Score (PSS), Fertility Problem Index (FPI), pregnancy rates, intention to pursue treatment and % pursuing treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05903638 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by One Fertility
Last refreshed: 15 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05903638.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing